LP
ASLN

LMR Partners’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

LMR Partners’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,304
Closed -$33.2K – 1193
2022
Q4 		$33.2K Hold
2,304
– – ﹤0.01% 1064
2022
Q3 		$55K Hold
2,304
– – ﹤0.01% 1091
2022
Q2 		$46K Hold
2,304
– – ﹤0.01% 1168
2022
Q1 		$83K Hold
2,304
– – ﹤0.01% 1192
2021
Q4 		$103K Hold
2,304
– – ﹤0.01% 1109
2021
Q3 		$164K Buy
+2,304
New +$262K ﹤0.01% 937

Other funds holding ASLN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
WW
Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

LMR Partners's ASLN Position: Q1 2023 in Review

LMR Partners sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2023, closing a stake of 2,304 shares — an estimated $33.2K sold.

LMR Partners first reported a position in ASLN in Q3 2021 and held it in 6 quarters. The position peaked at $164K in Q3 2021. 16 funds tracked by Wall St. Rank hold ASLN as of Q1 2023.

  • LMR Partners reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • LMR Partners sold 2,304 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2023, an estimated $33.2K.
  • LMR Partners first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2021 and held it in 6 quarters.
  • LMR Partners's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $164K in Q3 2021.
  • 16 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2023.

Based on LMR Partners's 13F filing for Q1 2023, filed 15 May 2023.